Spontaneous Regression of an Epidermal Growth Factor Receptor-mutant Left Upper Lobe Adenocarcinoma

被引:0
|
作者
Schiavon, Marco
Madrid, Andrea Lloret
Pezzuto, Federica
Giraudo, Chiara
Comacchio, Giovanni Maria
Faccioli, Eleonora
Dell'Amore, Andrea
Calabrese, Fiorella
Rea, Federico
机构
[1] Padova Univ Hosp, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Thorac Surg Div, Padua, Italy
[2] Padova Univ Hosp, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Pathol Div, Padua, Italy
[3] Padova Univ Hosp, Radiol Inst, Dept Med, Padua, Italy
来源
ANNALS OF THORACIC SURGERY | 2022年 / 114卷 / 04期
关键词
CIPROFLOXACIN;
D O I
10.1016/j.athoracsur.2021.11.064
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Spontaneous regression of cancer is a known mani-festation rarely described for thoracic malignancies. We present the case of a patient affected by an epidermal growth factor receptor-mutant adenocarci-noma who developed a contralateral aspiration pneu-monitis months before surgery and manifested a complete pathologic regression without any preopera-tive oncologic treatment. The underlying mechanisms are not clear, but immune system activation appears to be a key player, acting as a plausible trigger of a change in host response to cancer cells. The tumor microenvironment does not appear to be an "inert spectator" but rather an "active protagonist" on the course of the disease and its therapeutic targeting.(Ann Thorac Surg 2022;114:e261-e264) (c) 2022 by The Society of Thoracic Surgeons
引用
收藏
页码:E261 / E264
页数:4
相关论文
共 50 条
  • [31] Image-guided thermal ablation for patients with epidermal growth factor receptor-mutant nonsmall cell lung cancer
    Huang, Yahan
    Kong, Yongmei
    Wei, Zhigang
    Ye, Xin
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (04) : 427 - 433
  • [32] Epidermal growth factor receptor-mutant non-small cell lung Cancer and Choroidal metastases: long-term outcome and response to epidermal growth factor receptor tyrosine kinase inhibitors
    Bouchez, Clementine
    Pluvy, Johan
    Soussi, Ghassen
    Nguenang, Marina
    Brosseau, Solenn
    Tourne, Morgan
    Collin, Megane
    Theou-Anton, Nathalie
    Guyard, Alice
    Ammar, Jamila
    Khalil, Antoine
    Zalcman, Gerard
    Gounant, Valerie
    BMC CANCER, 2020, 20 (01)
  • [33] Current role and future direction of osimertinib in epidermal growth factor receptor-mutant non-small cell lung cancer
    Jeong, Byeong-Ho
    Um, Sang-Won
    JOURNAL OF THORACIC DISEASE, 2019, 11 (01) : 39 - 41
  • [34] Epidermal growth factor receptor-mutant non-small cell lung Cancer and Choroidal metastases: long-term outcome and response to epidermal growth factor receptor tyrosine kinase inhibitors
    Clémentine Bouchez
    Johan Pluvy
    Ghassen Soussi
    Marina Nguenang
    Solenn Brosseau
    Morgan Tourne
    Mégane Collin
    Nathalie Théou-Anton
    Alice Guyard
    Jamila Ammar
    Antoine Khalil
    Gérard Zalcman
    Valérie Gounant
    BMC Cancer, 20
  • [35] Successful Use of Afatinib After Erlotinib-induced Pneumonitis in a Patient With Epidermal Growth Factor Receptor-mutant Lung Cancer
    Jakubowski, Christopher D.
    Plodkowski, Andrew J.
    Chang, Jason C.
    Rekhtman, Natasha
    Iqbal, Afsheen
    Paik, Paul K.
    Yu, Helena A.
    CLINICAL LUNG CANCER, 2017, 18 (01) : E81 - E83
  • [36] Dramatic response to immunotherapy in an epidermal growth factor receptor-mutant non-small cell lung cancer:A case report
    Ding Li
    Cheng Cheng
    Wen-Ping Song
    Pei-Zan Ni
    Wen-Zhou Zhang
    Xuan Wu
    World Journal of Clinical Cases, 2021, (36) : 11419 - 11424
  • [37] Recurrent bilateral spontaneous pneumothorax secondary to lung adenocarcinoma with epidermal growth factor receptor mutation
    Chen, Wenhui
    Lin, Yingxiang
    Yu, Yanxia
    Wei, Ping
    Dai, Huaping
    THORACIC CANCER, 2016, 7 (02) : 257 - 260
  • [38] Prognostic Impact of Reactive Oxygen Species Modulator 1 in Surgically Resected Epidermal Growth Factor Receptor-Mutant Lung Adenocarcinomas
    Kim, Tae-Woo
    Na, Kiyong
    Jung, Junyang
    Lim, Heejin
    Seo, Hyewon
    Lee, Seung Hyeun
    ONCOLOGY, 2024, 102 (11) : 969 - 978
  • [39] Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitors
    Chen, Yu-Mu
    Lai, Chien-Hao
    Rau, Kun-Ming
    Huang, Cheng-Hua
    Chang, Huang-Chih
    Chao, Tung-Ying
    Tseng, Chia-Cheng
    Fang, Wen-Feng
    Chung, Yu-Hsiu
    Wang, Yi-Hsi
    Su, Mao-Chang
    Huang, Kuo-Tung
    Liu, Shih-Feng
    Chen, Hung-Chen
    Chang, Ya-Chun
    Chang, Yu-Ping
    Wang, Chin-Chou
    Lin, Meng-Chih
    BMC CANCER, 2016, 16
  • [40] Combination of Osimertinib with Durvalumab in Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer: Is There Room for Reinvestigation?
    Ahn, Myung-Ju
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (05) : 766 - 767